ALB and neoplasm: Albumin provides important features as a carrier platform: (1) high biocompatibility and lack of toxicity and immunogenicity; (2) a long half-life of 20 days in the bloodstream; (3) tumor accumulation by enhanced permeability and retention (EPR-effect) of macromolecules and receptor interaction; (4) robustness toward chemical modification; and (5) easily controlled surface chemistry [10,33,49,50,51,52,53,54,55,56,57].